Asper Biotech recently launched several new reprogenetic tests. The Tartu, Estonia-based firm uses arrayed primer extension to test fetal cells for specific genetic abnormalities.
New assays as a service from its lab include its carrier test, which enables users to determine the carrier status of 92 mutations linked to 19 disorders, including sickle-cell anemia, beta-thalassemia, Tay-Sachs disease, and others.
The company also offers array-based testing for mutations associated with congenital adrenal hyperplasia, Noonan syndrome, skeletal dysplasia, and Smith-Lemli-Opitz syndrome.
BioArray News spoke with executives from Asper in September about the firm's reprogenetics offerings (BAN 9/13/2011).